Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Enrolling by invitation

Conditions studied: Haemophilia A, Haemophilia B

In brief

The purpose of the study is to investigate the safety and effectiveness of Alhemo® in all participants under real-world clinical practice in Japan. Participants will get Alhemo® as prescribed by the study doctor. The study will last for about 2 years.

Key facts

Study ID

NCT06285071

Run by

Novo Nordisk A/S

People needed

23

Starts

2024-08-08

Expected to finish

2030-04-30

Last updated by the study team

2026-06-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol)
• The decision to initiate treatment with commercially available Alhemo® has been made by the patient/LAR and the treating physician before and independently from the decision to include the patient in this study
• Male or female patients, regardless of age
• Diagnosis with HAwI/HBwI

You may not qualify if…

• Previous participation in this study. Participation is defined as having given informed consent in this study

Where it is running

• Novo Nordisk Investigational Site — Toshima City, Tokyo, Japan
• Mutsu general hospital_Pediatrics — Aomori, Japan
• Kyushu university hospital_Pediatrics — Fukuoka, Japan
• Sapporo Tokushukai Hospital_Pediatrics — Hokkaido, Japan
• Kagoshima City Hospital_Pediatrics — Kagoshima, Japan
• St. Marianna University School of Medicine Hospital_Pediatrics — Kanagawa, Japan
• Hospital of the University of Occupational And Environmental Health Japan_Pediatrics — Kitakyusyu-shi, Fukuoka, Japan
• Nanbu Medical Center & Children's Medical Center_Hematology and Oncology — Okinawa, Japan
• University of the Ryukyus Hospital_Endocrinology and Metabolism, Hematology and Rheumatology — Okinawa, Japan
• Tokyo Medical University Hospital — Tokyo, Japan
• Ogikubo Hospital_Blood Coagulation — Tokyo, Japan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.